hydroxychloroquine has been researched along with Bleb in 5 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine in lower doses is an effective treatment for porphyria cutanea tarda; at doses used to treat systemic lupus erythematosus and subacute cutaneous lupus, there is a potentially life-threatening complication of hepatotoxicity." | 5.48 | The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. ( Ettel, M; McCune, WJ; Pearson, TL; Roofeh, D; Silver, S; Sunkara, B, 2018) |
| "Hydroxychloroquine in lower doses is an effective treatment for porphyria cutanea tarda; at doses used to treat systemic lupus erythematosus and subacute cutaneous lupus, there is a potentially life-threatening complication of hepatotoxicity." | 1.48 | The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. ( Ettel, M; McCune, WJ; Pearson, TL; Roofeh, D; Silver, S; Sunkara, B, 2018) |
| "Bullous systemic lupus erythematosus (SLE) is a kind of LE-non-specific bullous skin disease that is rarely induced by a medication." | 1.38 | Methimazole-induced bullous systemic lupus erythematosus: a case report. ( Byun, HJ; Cho, KH; Lee, EB; Seo, JY, 2012) |
| "Vesico-bullous subacute cutaneous lupus erythematosus is an uncommon and severe presentation." | 1.38 | Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine. ( Alves, R; Pinto-Almeida, T; Sanches, M; Selores, M, 2012) |
| "A treatment with hydroxychloroquine and topical corticosteroïds was effective in 3 months." | 1.31 | [Bullous localization of a lupus erythematosus induced by radiotherapy]. ( Beylot Barry, M; Beylot, C; Doutre, MS; Krim, E; Marrot, F; Noblesse, I; Vergier, B, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sunkara, B | 1 |
| Roofeh, D | 1 |
| Silver, S | 1 |
| Pearson, TL | 1 |
| Ettel, M | 1 |
| McCune, WJ | 1 |
| Avram, MM | 1 |
| Hoang, M | 1 |
| Seo, JY | 1 |
| Byun, HJ | 1 |
| Cho, KH | 1 |
| Lee, EB | 1 |
| Pinto-Almeida, T | 1 |
| Sanches, M | 1 |
| Alves, R | 1 |
| Selores, M | 1 |
| Krim, E | 1 |
| Noblesse, I | 1 |
| Beylot Barry, M | 1 |
| Vergier, B | 1 |
| Marrot, F | 1 |
| Doutre, MS | 1 |
| Beylot, C | 1 |
5 other studies available for hydroxychloroquine and Bleb
| Article | Year |
|---|---|
The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda.
Topics: Adult; Blister; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Dose-Response Relat | 2018 |
Case records of the Massachusetts General Hospital. Case 20-2009. A 79-year-old woman with a blistering cutaneous eruption.
Topics: Aged; Antirheumatic Agents; Blister; Diagnosis, Differential; Drug Eruptions; Female; Humans; Hydrox | 2009 |
Methimazole-induced bullous systemic lupus erythematosus: a case report.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Antithyroid Agents; Blister; Drug Therapy, Co | 2012 |
Vesico-bullous subacute cutaneous lupus erythematosus--an uncommon entity successfully treated with dapsone and hydroxychloroquine.
Topics: Antirheumatic Agents; Blister; Dapsone; Folic Acid Antagonists; Humans; Hydroxychloroquine; Lupus Er | 2012 |
[Bullous localization of a lupus erythematosus induced by radiotherapy].
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Blister; Dermatologic Agent | 2002 |